Amlodipine Besylate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Amlodipine Besylate Price Trend, Index and Forecast
Track the latest insights on amlodipine besylate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Amlodipine Besylate Prices Outlook Q2 2026
- USA: USD 76,338/MT
- China: USD 76,167/MT
- Germany: USD 76,310/MT
- India: USD 79,975/MT
- France: USD 77,836/MT
Amlodipine Besylate Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the second quarter of 2026, the amlodipine besylate prices in the USA reached 76,338 USD/MT in June. Prices increased as steady demand from healthcare facilities, pharmacies, and pharmaceutical manufacturers supported consistent procurement of this widely used antihypertensive ingredient. Growing requirements for cardiovascular treatments maintained regular consumption across the domestic market. Higher costs of key raw materials, including pharmaceutical intermediates, increased production expenses and encouraged manufacturers to revise quotations upward.
During the second quarter of 2026, the amlodipine besylate prices in China reached 76,167 USD/MT in June. Prices moved upward as sustained demand from the domestic pharmaceutical sector supported steady procurement activity. Pharmaceutical manufacturers continued maintaining production schedules for cardiovascular medications, supporting consumption of amlodipine besylate throughout the quarter. Higher production expenses, influenced by raw material costs and processing requirements, placed pressure on supplier margins and encouraged stronger market quotations.
During the second quarter of 2026, the amlodipine besylate prices in Germany reached 76,310 USD/MT in June. Prices increased as consistent demand from pharmaceutical manufacturers supported market activity for hypertension treatment applications. Healthcare requirements remained stable, encouraging regular procurement and maintaining demand for active pharmaceutical ingredients. Challenges associated with sourcing raw materials created additional cost pressure for producers, affecting overall production economics.
During the second quarter of 2026, the amlodipine besylate prices in India reached 79,975 USD/MT in June. Prices increased significantly as higher raw material procurement costs raised production expenses for manufacturers. India’s strong pharmaceutical manufacturing base supported steady demand for amlodipine besylate, driven by continued requirements for cardiovascular medicines in domestic and export markets. Limited supply availability created additional pressure as buyers competed for available material to maintain production schedules.
During the second quarter of 2026, the amlodipine besylate prices in France reached 77,836 USD/MT in June. Prices increased as demand from domestic healthcare providers and international pharmaceutical markets supported stronger procurement activity. Continued requirements for antihypertensive medications maintained stable consumption, while export demand contributed to tighter supply conditions. Rising logistics expenses, including transportation and distribution costs, increased the overall cost burden for suppliers and buyers.
Amlodipine Besylate Prices Outlook Q1 2025
- USA: USD 76,440/MT
- China: USD 72,411/MT
- Germany: USD 75,369/MT
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast, and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing amlodipine besylate prices.
Europe Amlodipine Besylate Price Trend
Q2 2026:
The amlodipine besylate price index in Europe moved upward as tighter delivered supply, export demand, and logistics constraints supported firmer offers. Supply chain disruptions and increased production costs have impacted pharmaceutical pricing, irrespective of temporary ethylene price relief within the quarter. Continuous demand from healthcare sectors and regulatory obligations required strategic purchasing strategies. Major pharmaceutical centers maintained consistent production, which prevented a more severe shortage scenario. Export demand absorbed available volumes, reducing chances of downward pricing adjustments.
This analysis can be extended to include detailed amlodipine besylate price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Amlodipine Besylate Price Trend
Q2 2026:
The amlodipine besylate price index in North America increased as consistent pharmaceutical demand and limited supply availability supported firmer market conditions. Hospitals, pharmacies, and pharmaceutical manufacturers maintained steady procurement activity due to the continued requirement for hypertension management medications. The need for reliable active pharmaceutical ingredient availability encouraged buyers to secure supplies in advance, reducing flexibility in spot market transactions. Export commitments from regional suppliers also influenced inventory levels by limiting immediately available volumes for domestic buyers. Rising costs associated with raw materials, chemical intermediates, and pharmaceutical production inputs increased manufacturing expenses and encouraged suppliers to adjust quotations upward.
Specific amlodipine besylate historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Amlodipine Besylate Price Trend
Q2 2026:
The analysis covers amlodipine besylate price trends across the Middle East and Africa, considering factors like regional health care demand growth, resource accessibility, and economic variations impacting pricing.
In addition to region-wise data, information on amlodipine besylate prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East and Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Amlodipine Besylate Price Trend
Q2 2026:
The amlodipine besylate price trend across Asia Pacific moved upward as steady pharmaceutical demand, rising production expenses, and supply constraints supported firmer market conditions. Demand from pharmaceutical manufacturers remained strong due to continued requirements for cardiovascular medicines used in hypertension management. Major regional producers faced increasing pressure from higher raw material costs, processing expenses, and quality compliance requirements, which influenced pricing strategies. China and India, as key pharmaceutical manufacturing hubs, experienced consistent procurement activity from domestic and export markets, limiting available inventories.
This amlodipine besylate price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Amlodipine Besylate Price Trend
Q2 2026:
The examination of amlodipine besylate prices in Latin America gives a thorough overview, representing the region's distinct market dynamics as influenced by economic policies, industrial expansion, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Amlodipine Besylate Pricing Report, Market Analysis, and News
IMARC's latest publication, “Amlodipine Besylate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the amlodipine besylate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of amlodipine besylate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents a detailed amlodipine besylate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting amlodipine besylate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Amlodipine Besylate Industry Analysis
The global amlodipine besylate market size reached USD 430.9 Million in 2025. By 2034, IMARC Group expects the market to reach USD 667.6 Million, at a projected CAGR of 4.84% during 2026-2034. The market is primarily driven by the increasing prevalence of cardiovascular diseases, rising healthcare expenditure, and growing demand for effective antihypertensive treatments.
Latest News and Developments:
- February 2024: Dr. Reddy’s Laboratories announced that they received a Voluntary Action Indicated (VAI) status from the United States Food and Drug Administration (USFDA) following an inspection of its research and development (R&D) centres for Integrated Product Development Organisation (IPDO) in Bachupally, Hyderabad.
- January 2024: Teva announced its intention to divest its active pharmaceutical ingredient (API) business, or “TAPI”. TAPI is a global leader in the small molecule API industry, with approximately 4,300 employees worldwide.
Product Description
Amlodipine besylate is a calcium channel blocker used primarily as an active pharmaceutical ingredient in antihypertensive medications to manage hypertension and angina. The compound is highly effective in dilating blood vessels, thereby reducing systemic vascular resistance and lowering blood pressure. It is synthesized through a chemical process involving the esterification of the dihydropyridine derivative with benzene sulfonic acid, producing a stable and potent therapeutic agent. Amlodipine besylate is preferred for its high bioavailability, prolonged half-life, and minimal side effects, making it suitable for once-daily dosing. The pharmaceutical industry extensively formulates it into oral tablets and capsules, catering to a wide patient demographic requiring long-term cardiovascular health management. Its availability in generic formulations has extended its reach, ensuring cost-effective treatment solutions across different healthcare systems globally.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Amlodipine Besylate |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Amlodipine Besylate Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of amlodipine besylate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting amlodipine besylate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The amlodipine besylate price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.